用于肿瘤靶向药物递送和癌症成像的基于混合量子点的诊疗纳米药物。 - Suppr

Suppr

超能文献

Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.

作者信息

Zayed Dina G, AbdElhamid Ahmed S, Freag May S, Elzoghby Ahmed O

机构信息

Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.

Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.

出版信息

Nanomedicine (Lond). 2019 Feb;14(3):225-228. doi: 10.2217/nnm-2018-0414. Epub 2019 Jan 17.

DOI:10.2217/nnm-2018-0414

PMID:30652951

Abstract

摘要

相似文献

Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.

Nanomedicine (Lond). 2019 Feb;14(3):225-228. doi: 10.2217/nnm-2018-0414. Epub 2019 Jan 17.

Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.

J Control Release. 2016 Dec 10;243:303-322. doi: 10.1016/j.jconrel.2016.10.023. Epub 2016 Oct 26.

Oligonucleotide-based theranostic nanoparticles in cancer therapy.

Nanomedicine (Lond). 2016 May;11(10):1287-308. doi: 10.2217/nnm-2016-0035. Epub 2016 Apr 22.

Prussian blue nanoparticles and their analogues for application to cancer theranostics.

Nanomedicine (Lond). 2016 Mar;11(6):569-72. doi: 10.2217/nnm.16.16. Epub 2016 Feb 25.

Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.

Small. 2017 Mar;13(10). doi: 10.1002/smll.201603121. Epub 2016 Dec 27.

Chondroitin sulfate derived theranostic nanoparticles for targeted drug delivery.

Biomater Sci. 2016 Aug 16;4(9):1310-3. doi: 10.1039/c6bm00335d.

[Supramolecular Agents for Theranostics].

Bioorg Khim. 2015 Sep-Oct;41(5):539-52. doi: 10.1134/s1068162015050052.

Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.

Mol Pharm. 2017 Oct 2;14(10):3539-3549. doi: 10.1021/acs.molpharmaceut.7b00560. Epub 2017 Sep 7.

Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.

Drug Discov Today. 2020 Jul;25(7):1245-1252. doi: 10.1016/j.drudis.2020.04.018. Epub 2020 May 1.

Coating microbubbles with nanoparticles for medical imaging and drug delivery.

Nanomedicine (Lond). 2017 Jan;12(2):91-94. doi: 10.2217/nnm-2016-0362. Epub 2016 Nov 23.

引用本文的文献

Nanotechnology in cancer therapeutics, diagnosis, and management.

BioTechnologia (Pozn). 2024 Sep 30;105(3):287-303. doi: 10.5114/bta.2024.141807. eCollection 2024.

Quantum Dot-based Bio-conjugates as an Emerging Bioimaging Tool for Cancer Theranostic- A Review.

Curr Drug Targets. 2024;25(4):241-260. doi: 10.2174/0113894501283669240123105250.

Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities.

ACS Omega. 2023 Apr 10;8(16):14290-14320. doi: 10.1021/acsomega.2c07840. eCollection 2023 Apr 25.

Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes.

ACS Omega. 2023 Jan 27;8(5):4491-4507. doi: 10.1021/acsomega.2c05986. eCollection 2023 Feb 7.

Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises.

Cancers (Basel). 2022 Nov 1;14(21):5389. doi: 10.3390/cancers14215389.

Quantum dots based in-vitro co-culture cancer model for identification of rare cancer cell heterogeneity.

Sci Rep. 2022 Apr 7;12(1):5868. doi: 10.1038/s41598-022-09702-y.

Nanomaterials: Synthesis and Applications in Theranostics.

Nanomaterials (Basel). 2021 Nov 28;11(12):3228. doi: 10.3390/nano11123228.

The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers.

Nanomaterials (Basel). 2021 Sep 30;11(10):2579. doi: 10.3390/nano11102579.

Nanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment.

Trends Endocrinol Metab. 2020 Jun;31(6):448-458. doi: 10.1016/j.tem.2020.02.001. Epub 2020 Mar 4.

A Lysosome-Targetable Fluorescence Probe Based on L-Cysteine-Polyamine-Morpholine-Modified Quantum Dots for Imaging in Living Cells.

Int J Nanomedicine. 2020 Mar 9;15:1611-1622. doi: 10.2147/IJN.S234927. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.

Nanomedicine (Lond). 2019 Feb;14(3):225-228. doi: 10.2217/nnm-2018-0414. Epub 2019 Jan 17.

Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.

J Control Release. 2016 Dec 10;243:303-322. doi: 10.1016/j.jconrel.2016.10.023. Epub 2016 Oct 26.

Oligonucleotide-based theranostic nanoparticles in cancer therapy.

Nanomedicine (Lond). 2016 May;11(10):1287-308. doi: 10.2217/nnm-2016-0035. Epub 2016 Apr 22.

Prussian blue nanoparticles and their analogues for application to cancer theranostics.

Nanomedicine (Lond). 2016 Mar;11(6):569-72. doi: 10.2217/nnm.16.16. Epub 2016 Feb 25.

Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.

Small. 2017 Mar;13(10). doi: 10.1002/smll.201603121. Epub 2016 Dec 27.

Chondroitin sulfate derived theranostic nanoparticles for targeted drug delivery.

Biomater Sci. 2016 Aug 16;4(9):1310-3. doi: 10.1039/c6bm00335d.

[Supramolecular Agents for Theranostics].

Bioorg Khim. 2015 Sep-Oct;41(5):539-52. doi: 10.1134/s1068162015050052.

Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.

Mol Pharm. 2017 Oct 2;14(10):3539-3549. doi: 10.1021/acs.molpharmaceut.7b00560. Epub 2017 Sep 7.

Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.

Drug Discov Today. 2020 Jul;25(7):1245-1252. doi: 10.1016/j.drudis.2020.04.018. Epub 2020 May 1.

Coating microbubbles with nanoparticles for medical imaging and drug delivery.

Nanomedicine (Lond). 2017 Jan;12(2):91-94. doi: 10.2217/nnm-2016-0362. Epub 2016 Nov 23.

引用本文的文献

Nanotechnology in cancer therapeutics, diagnosis, and management.

BioTechnologia (Pozn). 2024 Sep 30;105(3):287-303. doi: 10.5114/bta.2024.141807. eCollection 2024.

Quantum Dot-based Bio-conjugates as an Emerging Bioimaging Tool for Cancer Theranostic- A Review.

Curr Drug Targets. 2024;25(4):241-260. doi: 10.2174/0113894501283669240123105250.

Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities.

ACS Omega. 2023 Apr 10;8(16):14290-14320. doi: 10.1021/acsomega.2c07840. eCollection 2023 Apr 25.

Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes.

ACS Omega. 2023 Jan 27;8(5):4491-4507. doi: 10.1021/acsomega.2c05986. eCollection 2023 Feb 7.

Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises.

Cancers (Basel). 2022 Nov 1;14(21):5389. doi: 10.3390/cancers14215389.

Quantum dots based in-vitro co-culture cancer model for identification of rare cancer cell heterogeneity.

Sci Rep. 2022 Apr 7;12(1):5868. doi: 10.1038/s41598-022-09702-y.

Nanomaterials: Synthesis and Applications in Theranostics.

Nanomaterials (Basel). 2021 Nov 28;11(12):3228. doi: 10.3390/nano11123228.

The State of the Art of Theranostic Nanomaterials for Lung, Breast, and Prostate Cancers.

Nanomaterials (Basel). 2021 Sep 30;11(10):2579. doi: 10.3390/nano11102579.

Nanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment.

Trends Endocrinol Metab. 2020 Jun;31(6):448-458. doi: 10.1016/j.tem.2020.02.001. Epub 2020 Mar 4.

A Lysosome-Targetable Fluorescence Probe Based on L-Cysteine-Polyamine-Morpholine-Modified Quantum Dots for Imaging in Living Cells.

Int J Nanomedicine. 2020 Mar 9;15:1611-1622. doi: 10.2147/IJN.S234927. eCollection 2020.